Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × L-BLP25 × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Oxaliplatin 161 Capecitabine 149 Fluorouracil 139 Leucovorin 98 Radiotherapy 97 Irinotecan 83 Bevacizumab 61 Surgical Procedures, Operative 46 Drug Therapy 36 Cetuximab 34 Neoadjuvant Therapy 31 Radiation 29 Chemoradiotherapy 29 Folfox protocol 26 Chemotherapy, Adjuvant 20 XELOX 19 Radiotherapy, Intensity-Modulated 18 Proctectomy 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 14 Floxuridine 12 trifluridine tipiracil drug combination 11 Early Intervention, Educational 11 Biopsy 11 Panitumumab 10 Nivolumab 10 Laparoscopy 10 Immunohistochemistry 10 Consolidation Chemotherapy 10 regorafenib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01462513 2018-02-13

LICC

Johannes Gutenberg University Mainz

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡